Butylphthalide

丁苯酞

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameButylphthalide
Drug Alias Name丁基邻苯甲酸内酯dl-NBP丁基酞内酯Butilftalida丁基苯酞 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTandem pore domain potassium channels inhibitorsPlatelet aggregation inhibitors
TargetsTandem pore domain potassium channels
Therapy Area/IndicationsVascular restenosisST Elevation Myocardial InfarctionPeripheral Nervous System Diseases +[5] 
Global Approved IndicationsStroke
Approved Indications in ChinaStroke
Original Approved Country/TerritoryMainland China
Original Approved Date2002/09/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCspc Ouyi Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCSPC Pharmaceutical Group LtdCapital Medical UniversityCspc-Nbp Pharmaceutical Co Ltd +[5] 
Inactive CompaniesConjupro Biotherapeutics Inc
Active IndicationsST Elevation Myocardial InfarctionPeripheral Nervous System DiseasesStroke +[4] 
Inactive IndicationsVascular restenosis

Other Information

ATC CodeB01
Related LinksWikipedia